Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Anstrom

Showing results (1-10 of 328) with videos related to

Pageof 33
Sort By:
Biometrics|May 28, 2024
Integrating randomized and observational studies to estimate optimal dynamic treatment regimesAnna Batorsky, Kevin J Anstrom, Donglin Zeng
Biometrics|June 11, 2009
A generalized estimator of the attributable benefit of an optimal treatment regimeJason Brinkley, Anastasios Tsiatis, Kevin J Anstrom
Journal of Cardiac Failure|June 3, 2008
A global ranking approach to end points in trials of mechanical circulatory support devicesG Michael Felker, Kevin J Anstrom, Joseph G Rogers
Circulation|April 2, 2003
Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network DatabaseDarren K McGuire, Kevin J Anstrom, Eric D Peterson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatmentShelby D Reed, Yanhong Li, Kevin J Anstrom, et al.
Pharmacoeconomics|April 24, 2008
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemiaShelby D Reed, Kevin J Anstrom, Yanhong Li, et al.
Journal of Clinical and Translational Science|December 25, 2025
Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trialauEyal Kedar, Dima Dandachi, Alexis Bryant, et al.
Journal of General Internal Medicine|March 14, 2007
Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptionsNancy M Allen LaPointe, Paul Pappas, Patricia Deverka, et al.
Journal of Clinical and Translational Science|January 15, 2026
Erratum: Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial - CORRIGENDUMEyal Kedar, Dima Dandachi, Alexis Bryant, et al.
Medical Care|April 15, 2004
The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel SurveyLesley H Curtis, Amy W Law, Kevin J Anstrom, et al.
Pageof 33

Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Biometrics|May 28, 2024
Integrating randomized and observational studies to estimate optimal dynamic treatment regimesAnna Batorsky, Kevin J Anstrom, Donglin Zeng
Biometrics|June 11, 2009
A generalized estimator of the attributable benefit of an optimal treatment regimeJason Brinkley, Anastasios Tsiatis, Kevin J Anstrom
Journal of Cardiac Failure|June 3, 2008
A global ranking approach to end points in trials of mechanical circulatory support devicesG Michael Felker, Kevin J Anstrom, Joseph G Rogers
Circulation|April 2, 2003
Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network DatabaseDarren K McGuire, Kevin J Anstrom, Eric D Peterson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatmentShelby D Reed, Yanhong Li, Kevin J Anstrom, et al.
Pharmacoeconomics|April 24, 2008
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemiaShelby D Reed, Kevin J Anstrom, Yanhong Li, et al.
Journal of Clinical and Translational Science|December 25, 2025
Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trialauEyal Kedar, Dima Dandachi, Alexis Bryant, et al.
Journal of General Internal Medicine|March 14, 2007
Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptionsNancy M Allen LaPointe, Paul Pappas, Patricia Deverka, et al.
Journal of Clinical and Translational Science|January 15, 2026
Erratum: Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial - CORRIGENDUMEyal Kedar, Dima Dandachi, Alexis Bryant, et al.
Medical Care|April 15, 2004
The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel SurveyLesley H Curtis, Amy W Law, Kevin J Anstrom, et al.
Pageof 33